Division of Experimental Medicine
Newsletter - Celebrating Integrated Success
We could blog and Twitter (maybe one day we'll invent a new medium) but we have decided to stick with the tried and tested device of communicating key messages and successes in one epistle. At least we aren't using pigeons.
Newsletter - April 2012 - CPG6 and Division of Experimental Medicine 
Professor Martin Wilkins, Head of Experimental Medicine and Director of CPG-6
Centre for Haematology
Led by Professor Jane Apperley, the Centre for Haematology is based mainly on the Hammersmith Campus. Research interests include leukaemia, especially chronic myeloid leukaemia; lymphoma; myeloma; abnormalities of fetal haematology; haemophilia; and thrombophilia.
Centre for Pathology
-
Histopathology, the study of disease in tissue, provides a visual aspect to translational medicine by investigating cell-cell interaction within tissue sections by H&E sections and immunohistochemistry to identify cellular detail.
Centre for Pharmacology & Therapeutics
-
Led by Professor Martin Wilkins, the Centre for Pharmacology & Therapeutics comprises 2 units: Acute Medicine and Pharmacology and Therapeutics. It is based mainly on the 5th floor of the Burlington Danes Building, Hammersmith Hospital.
NIHR/Wellcome Trust Imperial College Research Facility
-
The NIHR/Wellcome Trust Imperial CRF is a dedicated early phase clinical studies unit on the Hammersmith campus
.
Imperial College Clinical Imaging Facility
-
A new research imaging facility at Imperial College will launch in early 2013. Established within the Department of Medicine, the Imperial College Clinical Imaging Facility (ICCIF or CIF) houses PET and MRI facilities.
Clinical Programme Group 6 (CPG6)
The Division of Experimental Medicine maps onto Clinical Programme Group 6 (CPG6) – Clinical and Investigative Sciences – within the NHS Trust. Its mission is to facilitate translational medicine.
As such it takes clinical and scientific responsibility for the NIHR/Wellcome Trust Imperial CRF . The Division co-ordinates the resources of CPG6, namely Imaging, Molecular Pathology, Pharmacy, Clinical Trial Methodology and Research Governance, to form a Centre for Translational Medicine.
